Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension (vol 69, pg 718, 2010)

被引：0
|
作者：
Ruperto, Nicolino
机构：
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2011年 / 70卷 / 11期
关键词：
D O I：
10.1136/ard.2008.100354corr1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
    Ruperto, Nicolino
    Lovell, Daniel J.
    Cuttica, Ruben
    Woo, Patricia
    Meiorin, Silvia
    Wouters, Carine
    Silverman, Earl D.
    Balogh, Zsolt
    Henrickson, Michael
    Davidson, Joyce
    Foeldvari, Ivan
    Imundo, Lisa
    Simonini, Gabriele
    Oppermann, Joachim
    Xu, Stephen
    Shen, Yaung-Kaung
    Visvanathan, Sudha
    Fasanmade, Adedigbo
    Mendelsohn, Alan
    Martini, Alberto
    Giannini, Edward H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (04) : 718 - 722
  • [2] Long-Term Efficacy and Safety of Infliximab plus Methotrexate for The Treatment of Polyarticular Course Juvenile Rheumatoid Arthritis: Findings from an Open-Label Treatment Extension (vol 69, pg 585, 2010)
    Ruperto, Nicolino
    Lovell, Daniel J.
    Cuttica, Ruben
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) : 1106 - 1106
  • [3] Long-term efficacy & safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis: Findings from an open-label treatment extension.
    Lovell, D. J.
    Ruperto, N.
    Cuttica, R.
    Woo, P.
    Espada, G.
    Wouters, C.
    Silverman, E. D.
    Balogh, Z.
    Henrickson, M.
    Davidson, J.
    Foeldvari, I.
    Imundo, L.
    Simonini, G.
    Oppermann, J.
    Shen, Y. K.
    Visvanathan, S.
    Fasanmade, A.
    Mendelsohn, A.
    Giannini, E. H.
    Martini, A.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S632 - S632
  • [4] 2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension
    N Ruperto
    DJ Lovell
    R Cuttica
    P Woo
    G Espada
    C Wouters
    ED Silverman
    Z Balogh
    M Henrickson
    J Davidson
    I Foeldvari
    L Imundo
    G Simonini
    J Oppermann
    YK Shen
    S Visvanathan
    A Fasanmade
    A Mendelsohn
    A Martini
    EH Giannini
    [J]. Pediatric Rheumatology, 6 (Suppl 1)
  • [5] Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis
    Silverman, E
    Spiegel, L
    Hawkins, D
    Petty, R
    Goldsmith, D
    Schanberg, L
    Duffy, C
    Howard, P
    Strand, V
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (02): : 554 - 562
  • [6] Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis
    Lovell, DJ
    Reiff, A
    Jones, OY
    Schneider, R
    Nocton, J
    Stein, LD
    Gedalia, A
    Ilowite, NT
    Wallace, CA
    Whitmore, JB
    White, B
    Giannini, EH
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (06): : 1987 - 1994
  • [7] Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis - Interim results from an ongoing multicenter, open-label, extended-treatment trial
    Lovell, DJ
    Giannini, EH
    Reiff, A
    Jones, OY
    Schneider, R
    Olson, JC
    Stein, LD
    Gedalia, A
    Ilowite, NT
    Wallace, CA
    Lange, M
    Finck, BK
    Burge, DJ
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (01): : 218 - 226
  • [8] Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan
    Mori, Masaaki
    Takei, Syuji
    Imagawa, Tomoyuki
    Imanaka, Hiroyuki
    Nerome, Yasuhito
    Higuchi, Rumiko
    Kawano, Yoshifumi
    Yokota, Shumpei
    Sugiyama, Noriko
    Yuasa, Hirotoshi
    Fletcher, Tracey
    Wajdula, Joseph S.
    [J]. MODERN RHEUMATOLOGY, 2012, 22 (05) : 720 - 726
  • [9] A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
    Ruperto, Nicolino
    Lovell, Daniel J.
    Cuttica, Ruben
    Wilkinson, Nick
    Woo, Patricia
    Espada, Graciela
    Wouters, Carine
    Silverman, Earl D.
    Balogh, Zsolt
    Henrickson, Michael
    Apaz, Maria-Teresa
    Baildam, Eileen
    Fasth, Anders
    Gerloni, Valeria
    Lahdenne, Pekka
    Prieur, Anne-Marie
    Ravelli, Angelo
    Saurenmann, Rotraud K.
    Luz Gamir, Maria
    Wulffraat, Nico
    Marodi, Laszlo
    Petty, Ross E.
    Joos, Rik
    Zulian, Francesco
    McCurdy, Deborah
    Myones, Barry L.
    Nagy, Kalman
    Reuman, Peter
    Szer, Ilona
    Travers, Suzanne
    Beutler, Anna
    Keenan, Greg
    Clark, Jason
    Visvanathan, Sudha
    Fasamnade, Adedigbo
    Raychaudhuri, Aparna
    Mendelsohn, Alan
    Martini, Alberto
    Giannini, Edward H.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (09): : 3096 - 3106
  • [10] Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial
    Brunner, Hermine I.
    Ruperto, Nicolino
    Zuber, Zbigniew
    Cuttica, Ruben
    Keltsev, Vladimir
    Xavier, Ricardo M.
    Burgos-Vargas, Ruben
    Penades, Inmaculada Calvo
    Silverman, Earl D.
    Espada, Graciela
    Zavaler, Manuel Ferrandiz
    Kimura, Yukiko
    Duarte, Carolina
    Job-Deslandre, Chantal
    Joos, Rik
    Douglass, Wendy
    Wimalasundera, Sunethra
    Bharucha, Kamal N.
    Wells, Chris
    Lovell, Daniel J.
    Martini, Alberto
    de Benedetti, Fabrizio
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (03) : 530 - 541
12345